# Guo's Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: a Multicenter Pilot Study(GRAFT Study)

> **NCT05754541** · NA · UNKNOWN · sponsor: **Hangzhou Endonom Medtech Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Aortic Aneurysm and Dissection

## Interventions

- **DEVICE:** WeFlow-Tribranch Aortic Arch Stent Graft System

## Key facts

- **NCT ID:** NCT05754541
- **Lead sponsor:** Hangzhou Endonom Medtech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-10
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05754541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05754541, "Guo's Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: a Multicenter Pilot Study(GRAFT Study)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05754541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*